TrialReproductive biology and endocrinology : RB&E2020

A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management of chronic cyclical pelvic pain.

Sallwa M Alshehre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.